Letter: histologic disease activity and colorectal neoplasia risk
- PMID: 37243459
- DOI: 10.1111/apt.17528
Letter: histologic disease activity and colorectal neoplasia risk
Comment in
-
Letter: histologic disease activity and colorectal neoplasia risk-authors' reply.Aliment Pharmacol Ther. 2023 Jun;57(12):1481. doi: 10.1111/apt.17536. Aliment Pharmacol Ther. 2023. PMID: 37243469 No abstract available.
Comment on
-
Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post-inflammatory polyps.Aliment Pharmacol Ther. 2023 Jun;57(12):1445-1452. doi: 10.1111/apt.17495. Epub 2023 Mar 31. Aliment Pharmacol Ther. 2023. PMID: 37002640
References
REFERENCES
-
- Wolf T, Lewis A, Beaugerie L, Svrcek M, Kirchgesner J, for the Saint-Antoine IBD Network. Risk of colorectal neoplasia according to histologic disease activity in patients with inflammatory bowel disease and colonic post-inflammatory polyps. Aliment Pharmacol Ther. 2023;57:1445-52.
-
- Kirchgesner J, Svrcek M, Le Gall G, Landman C, Dray X, Bourrier A, et al. Nancy index scores of chronic inflammatory bowel disease activity associate with development of colorectal neoplasia. Clin Gastroenterol Hepatol. 2020;18(1):150-157 e151.
-
- Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut. 2006;55(2):285-91.
-
- Jain A, Nguyen NH, Proudfoot JA, Martin CF, Sandborn WJ, Kappelman MD, et al. Impact of obesity on disease activity and patient-reported outcomes measurement information system (PROMIS) in inflammatory bowel diseases. Am J Gastroenterol. 2019;114(4):630-9.
-
- Grimsdottir S, Attauabi M, Dahl EK, Burisch J, Seidelin JB. Systematic review with meta-analysis: the impact of cancer treatments on the disease activity of inflammatory bowel diseases. J Crohns Colitis. 2023. https://doi.org/10.1093/ecco-jcc/jjad010
Publication types
MeSH terms
LinkOut - more resources
Medical